Log in

Corbus Pharmaceuticals News Headlines (NASDAQ:CRBP)

$5.13
+0.18 (+3.64 %)
(As of 12/8/2019 09:15 AM ET)
Today's Range
$4.91
Now: $5.13
$5.15
50-Day Range
$4.29
MA: $4.85
$5.43
52-Week Range
$4.18
Now: $5.13
$9.11
Volume486,966 shs
Average Volume731,518 shs
Market Capitalization$331.76 million
P/E RatioN/A
Dividend YieldN/A
Beta1.81

Headlines

Corbus Pharmaceuticals (NASDAQ CRBP) News Headlines

Source:
DateHeadline
Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Receives Average Rating of "Buy" from BrokeragesCorbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - November 28 at 4:34 AM
Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Expected to Post Quarterly Sales of $4.64 MillionCorbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Expected to Post Quarterly Sales of $4.64 Million
www.americanbankingnews.com - November 28 at 2:06 AM
Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Expected to Post Earnings of -$0.33 Per ShareCorbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Expected to Post Earnings of -$0.33 Per Share
www.americanbankingnews.com - November 26 at 4:30 PM
Corbus Pharma completes patient enrollment in mid-stage lenabasum study for CFCorbus Pharma completes patient enrollment in mid-stage lenabasum study for CF
seekingalpha.com - November 18 at 12:42 PM
Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic FibrosisCorbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
finance.yahoo.com - November 18 at 12:42 PM
Edited Transcript of CRBP earnings conference call or presentation 7-Nov-19 1:30pm GMTEdited Transcript of CRBP earnings conference call or presentation 7-Nov-19 1:30pm GMT
finance.yahoo.com - November 14 at 8:00 PM
Corbus Pharmaceuticals Holdings Inc to Post FY2019 Earnings of ($1.11) Per Share, Jefferies Financial Group Forecasts (NASDAQ:CRBP)Corbus Pharmaceuticals Holdings Inc to Post FY2019 Earnings of ($1.11) Per Share, Jefferies Financial Group Forecasts (NASDAQ:CRBP)
www.americanbankingnews.com - November 13 at 10:20 AM
We Think Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Can Afford To Drive Business GrowthWe Think Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Can Afford To Drive Business Growth
finance.yahoo.com - November 12 at 12:05 PM
Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in LondonCorbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London
finance.yahoo.com - November 12 at 12:05 PM
Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual MeetingCorbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting
finance.yahoo.com - November 11 at 10:41 AM
Is Corbus Pharmaceuticals Stock a Buy?Is Corbus Pharmaceuticals Stock a Buy?
www.nasdaq.com - November 7 at 1:07 PM
Corbus Pharmaceuticals (CRBP) Reports Q3 Loss, Tops Revenue EstimatesCorbus Pharmaceuticals (CRBP) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 7 at 1:07 PM
Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate UpdatesCorbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
finance.yahoo.com - November 7 at 8:06 AM
Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Operational and Financial Results on November 7, 2019Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Operational and Financial Results on November 7, 2019
finance.yahoo.com - November 4 at 8:49 AM
Were Hedge Funds Right About Selling Corbus Pharmaceuticals (CRBP)?Were Hedge Funds Right About Selling Corbus Pharmaceuticals (CRBP)?
finance.yahoo.com - November 1 at 3:58 PM
What Percentage Of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Do Insiders Own?What Percentage Of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Do Insiders Own?
finance.yahoo.com - October 13 at 3:00 PM
Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual MeetingCorbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting
finance.yahoo.com - October 3 at 4:44 PM
Health Check: How Prudently Does Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Use Debt?Health Check: How Prudently Does Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Use Debt?
finance.yahoo.com - September 13 at 2:19 PM
Corbus Pharmaceuticals And Lenabasum In Systemic SclerosisCorbus Pharmaceuticals And Lenabasum In Systemic Sclerosis
seekingalpha.com - September 10 at 4:48 PM
Have Insiders Been Buying Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares This Year?Have Insiders Been Buying Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares This Year?
finance.yahoo.com - August 14 at 10:52 AM
Corbus Pharmaceuticals Holdings Inc (CRBP) COO Robert Paul Discordia Bought $87,900 of SharesCorbus Pharmaceuticals Holdings Inc (CRBP) COO Robert Paul Discordia Bought $87,900 of Shares
finance.yahoo.com - August 13 at 12:23 PM
Edited Transcript of CRBP earnings conference call or presentation 8-Aug-19 12:30pm GMTEdited Transcript of CRBP earnings conference call or presentation 8-Aug-19 12:30pm GMT
finance.yahoo.com - August 12 at 12:05 PM
What Youll Want to Know About Corbus Pharmaceuticals Q2 ResultsWhat You'll Want to Know About Corbus Pharmaceuticals' Q2 Results
www.fool.com - August 8 at 4:52 PM
Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q2 2019 Results - Earnings Call TranscriptCorbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 4:52 PM
What You'll Want to Know About Corbus Pharmaceuticals' Q2 ResultsWhat You'll Want to Know About Corbus Pharmaceuticals' Q2 Results
finance.yahoo.com - August 8 at 4:52 PM
Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate UpdatesCorbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates
www.nasdaq.com - August 8 at 12:02 PM
Corbus Pharmaceuticals EPS beats by $0.20, beats on revenueCorbus Pharmaceuticals EPS beats by $0.20, beats on revenue
seekingalpha.com - August 8 at 12:02 PM
Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates 
finance.yahoo.com - August 8 at 12:02 PM
Corbus Pharmaceuticals (CRBP) Q2 Earnings and Revenues Beat EstimatesCorbus Pharmaceuticals (CRBP) Q2 Earnings and Revenues Beat Estimates
finance.yahoo.com - August 8 at 12:02 PM
How Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Can Impact Your Portfolio VolatilityHow Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Can Impact Your Portfolio Volatility
finance.yahoo.com - July 12 at 4:32 PM
Corbus Pharmaceuticals to Host 2019 R&D Day in New York CityCorbus Pharmaceuticals to Host 2019 R&D Day in New York City
finance.yahoo.com - June 17 at 12:32 PM
Corbus up 3% premarket on positive lenabasum data in rare autoimmune disordersCorbus up 3% premarket on positive lenabasum data in rare autoimmune disorders
seekingalpha.com - June 12 at 2:33 PM
Lenabasum Open-Label Extension Data to be Presented at EULAR 2019 Continue to Show a Favorable Safety Profile and Improvement in Efficacy Outcomes in Systemic Sclerosis and Dermatomyositis Phase 2 StudiesLenabasum Open-Label Extension Data to be Presented at EULAR 2019 Continue to Show a Favorable Safety Profile and Improvement in Efficacy Outcomes in Systemic Sclerosis and Dermatomyositis Phase 2 Studies
finance.yahoo.com - June 12 at 2:33 PM
Edited Transcript of CRBP earnings conference call or presentation 9-May-19 12:30pm GMTEdited Transcript of CRBP earnings conference call or presentation 9-May-19 12:30pm GMT
finance.yahoo.com - June 11 at 11:38 AM
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in JuneCorbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in June
finance.yahoo.com - May 29 at 11:16 AM
Understanding Medical Cannabis vs. Recreational Cannabis StocksUnderstanding Medical Cannabis vs. Recreational Cannabis Stocks
finance.yahoo.com - May 29 at 11:16 AM
Corbus Pharmaceuticals Announces Presentation of Six Abstracts at EULAR 2019 Annual MeetingCorbus Pharmaceuticals Announces Presentation of Six Abstracts at EULAR 2019 Annual Meeting
finance.yahoo.com - May 28 at 11:28 AM
Does Corbus Pharmaceuticals Holdings, Inc.s (NASDAQ:CRBP) CEO Pay Compare Well With Peers?Does Corbus Pharmaceuticals Holdings, Inc.'s (NASDAQ:CRBP) CEO Pay Compare Well With Peers?
finance.yahoo.com - May 24 at 11:19 AM
Does Corbus Pharmaceuticals Holdings, Inc.'s (NASDAQ:CRBP) CEO Pay Compare Well With Peers?Does Corbus Pharmaceuticals Holdings, Inc.'s (NASDAQ:CRBP) CEO Pay Compare Well With Peers?
finance.yahoo.com - May 24 at 11:19 AM
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in MayCorbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May
finance.yahoo.com - May 15 at 11:37 AM
Corbuss OLE Data Is Fools Gold For Biotech Treasure HuntersCorbus's OLE Data Is Fool's Gold For Biotech Treasure Hunters
seekingalpha.com - May 14 at 11:56 AM
CRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class ActionCRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class Action
finance.yahoo.com - May 13 at 11:44 AM
FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmFINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - May 13 at 11:44 AM
3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - May 11 at 11:39 AM
Bronstein, Gewirtz & Grossman, LLC Class Action: BPI, CRBP & NIOBronstein, Gewirtz & Grossman, LLC Class Action: BPI, CRBP & NIO
finance.yahoo.com - May 10 at 11:54 AM
DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmDEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - May 10 at 11:54 AM
Corbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q1 2019 Results - Earnings Call TranscriptCorbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 4:01 PM
Corbus Pharma down 6% on Q1 missCorbus Pharma down 6% on Q1 miss
seekingalpha.com - May 9 at 11:52 AM
Corbus Pharmaceuticals Reports 2019 First Quarter Financial Results and Provides Clinical UpdatesCorbus Pharmaceuticals Reports 2019 First Quarter Financial Results and Provides Clinical Updates
www.globenewswire.com - May 9 at 11:52 AM
Corbus Pharmaceuticals misses by $0.36, misses on revenueCorbus Pharmaceuticals misses by $0.36, misses on revenue
seekingalpha.com - May 9 at 11:52 AM
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Featured Article: 52-Week High/Low

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel